nanoMAG

nanoMAG is a private U.S. medical device and biomaterials company developing bioabsorbable magnesium-based implant technology for temporary structural support in surgery. Its core technology, BioMg 250, is a patented magnesium alloy designed to provide fixation strength during healing and then resorb, potentially avoiding secondary implant-removal procedures. The company’s initial commercial focus is craniomaxillofacial fixation, with additional development activity in orthopedic, spine, dental, sports medicine, and vascular access applications. nanoMAG has supported its development through NIH/SBIR funding and preclinical studies aimed at enabling FDA IDE submission and subsequent De Novo or 510(k)-related commercialization pathways. The business appears to be primarily a platform biomaterials company built around applying its magnesium alloy across multiple implant categories.